SAN DIEGO--(BUSINESS WIRE)--Jan. 12, 2006--PURE Bioscience (OTCBB:PURE) today announced that D. Michael Sitton has joined its Board of Directors. Sitton brings a vast knowledge base and relationships within key strategic industries, including retail and commercial product distribution and food processing. “I have joined PURE’s Board because I believe in its patented antimicrobial technology and am confident that I can be materially helpful in the Company’s growth as I tap the resources in my diverse background to help advance PURE Bioscience’s new silver dihydrogen citrate platform technology into new markets,” stated Sitton. “I look forward to working with management to help shape the Company’s business development strategy as we strive to expand awareness and acceptance of SDC as a next-generation antimicrobial technology. I have identified and have begun to approach key individuals, companies and government agencies that have or I believe should have great interest in using SDC for applications including food processing and packaging, institutional infectious disease control and emergency response.”
